about
Clinical utility and patient considerations in the use of the sitagliptin-metformin combination in Chinese patientsUtilization patterns of insulin therapy and healthcare services among Japanese insulin initiators during their first year: a descriptive analysis of administrative hospital dataSafety, tolerability, and efficacy of insulin aspart in people with type 2 diabetes, as biphasic insulin aspart or with Basal insulin: findings from the multinational, non-interventional a1chieve study.A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus.Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diversity in diabetes: the role of insulin aspart.
@en
Diversity in diabetes: the role of insulin aspart.
@nl
type
label
Diversity in diabetes: the role of insulin aspart.
@en
Diversity in diabetes: the role of insulin aspart.
@nl
prefLabel
Diversity in diabetes: the role of insulin aspart.
@en
Diversity in diabetes: the role of insulin aspart.
@nl
P2093
P2860
P356
P1476
Diversity in diabetes: the role of insulin aspart.
@en
P2093
Avideh Nazeri
David R McCance
Etie Moghissi
Olga Kordonouri
P2860
P356
10.1002/DMRR.1240
P50
P577
2012-01-01T00:00:00Z